Hematology Diagnostics Market Report Statistics

• Global hematology diagnostics market revenue is estimated to reach USD 12.3 Billion by 2030 with a CAGR of 5.8% from 2022 to 2030
• North America hematology diagnostics market share accounted for over 45% shares in 2021
• According to WHO, 1,898,160 new cancer cases and 608,570 cancer deaths occurred in the United States
• Asia-Pacific hematology diagnostics market growth will register swift CAGR from 2022 to 2030
• Based on product, consumables acquired over 65% of the overall market share in 2021
• Among end-use, hospitals acquired over 40% market chunk in 2021
• Growing incidence of chronic disorders will fuel the global hematology diagnostics market value
• Advancement in hematology treatment is a popular hematology diagnostics market trend that is fueling the industry demand

The rising prevalence of cancer is one of the primary factors driving the global hematology diagnostics market revenue. According to the American Cancer Society, Inc., there will be over 1.9 million new cancer cases diagnosed worldwide in 2021. Aside from that, over 608,000 people died from cancer in the same year. Blood cancer is one of the most common types of cancer, and it affects almost everyone regardless of age. As a result of the growing number of blood cancers and other blood-related disorders, the demand for hematology diagnostics is increasing.

Global Hematology Diagnostics Market Dynamics

Market Drivers

• Growing prevalence of hematology disorders
• Increasing incidence of leukemia
• Rising awareness regarding blood disorders

Market Restraints

• High cost of hematology procedures
• Growing product recalls

Market Opportunities

• Development of highly advanced hematology analyzers
• Rising trend of point-of-care (POC) hematology diagnostics

Hematology Diagnostics Market Report Coverage

Hematology Diagnostics Market Growth Factors

The rise in the frequency of blood disorders, the introduction of technologically enhanced automated hematology analyzers, technological advancements, and growing awareness among people are some of the fundamental factors which are responsible for the growth of the hematology diagnostics market globally. Huge demand for lab automation and increment in consolidation among market players and diagnostic labs are key factors that are driving the worldwide hematology diagnostics market during the forecast period. Point-Of-Care (POC) hematology tests are easy to understand as they diminish the requirement for user training alongside enabling remote testing. Besides, these tests decrease the turnaround time. The rising adoption of these tests is foreseen to fuel the market growth over the estimated time frame. Expanding number of diagnostic centers and accessibility of advanced instruments are expected to fuel the demand for hematology diagnostics. However, the high cost of automated instruments and lack of awareness among people in developing economies may hamper the growth of the hematology diagnostics market growth.

Hematology Diagnostics Market Segmentation

The global hematology diagnostics market is segmented based on product, test type, end-use, and geography.

Hematology Diagnostics Market By Product

• Instrument
  • Analyzers
  • Flow Cytometers
  • Others
• Consumables
  • Reagents
  • Stains
  • Others

According to our hematology diagnostics industry analysis, consumables acquired the largest market share in 2021. Consumables are further divided into reagents, stains, and others. The high demand for consumables is credited to the growing diagnosis of blood disorders and other infections. Then again, the increased awareness among consumers and early detection of blood disorders is also fueling the consumables industry during the projected timeframe from 2022 to 2030.

Hematology Diagnostics Market By Test Type

• Blood Count
• Platelet Function
• Hemoglobin
• Hematocrit

Based on test type, the blood count sub-segment generated the largest revenue in 2021 and is expected to continue its trend during the forecast period 2022 to 2030. Blood count tests such as complete blood count (CBC) tests are carried out for routine check-ups and are useful for general health evaluation. Several conditions such as anemia, allergy, vitamin and iron deficiencies, and infections, are easily diagnosed through these tests.

Hematology Diagnostics Market By End-Use

• Hospitals
• Diagnostic Labs
• Others

According to our hematology diagnostics market forecast, hospitals will hold a sizable market share in 2021. The diagnostic labs segment, on the other hand, is expected to grow rapidly over the forecast period. The growing number of diagnostic centers and the availability of advanced instruments are expected to drive demand in the hospitals segment. Furthermore, automation in the field of hematology diagnostics has allowed hematology diagnostics hospitals and laboratories to be a focus of research and development activities.

Hematology Diagnostics Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

The Middle East & Africa

• South Africa
• GCC Countries
• Rest of the Middle East & Africa (ME&A)

Hematology Diagnostics Market Regional Analysis

In terms of revenue, North America dominated the market in 2021. This growth can be attributed to key factors such as an ever-increasing geriatric population, a favorable reimbursement scenario, sophisticated technological facilities, and the introduction of advanced technologies for the POC test.

Japan is anticipated to provide the most market opportunity in the Asia-Pacific region. This is because Japan has a fully advanced healthcare system as well as a large geriatric population. Emerging markets such as India and China are expected to drive significant market growth.

Hematology Diagnostics Market Players

Key companies profiled in this report involve Abbott Laboratories, Ortho Clinical Diagnostics, HORIBA, Ltd., Sysmex Corporation, Boule Diagnostics, F. Hoffmann-La Roche Ltd., Drew Scientific, Bio-Rad Laboratories, EKF Diagnostics, and Beckman Coulter, Inc.